Free Trial
ETR:MOR

MorphoSys (MOR) Stock Price, News & Analysis

MorphoSys logo
€67.25 0.00 (0.00%)
As of 08/20/2024

About MorphoSys Stock (ETR:MOR)

Key Stats

Today's Range
€66.70
€67.30
50-Day Range
€67.25
€67.25
52-Week Range
€14.52
€69.75
Volume
5,144 shs
Average Volume
153,687 shs
Market Capitalization
€2.53 billion
P/E Ratio
N/A
Dividend Yield
1.26%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MOR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MOR Stock News Headlines

Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.tc pixel
Novartis raises sales guidance until 2028
See More Headlines

MOR Stock Analysis - Frequently Asked Questions

MorphoSys' stock was trading at €67.25 on January 1st, 2025. Since then, MOR stock has increased by 0.0% and is now trading at €67.25.

Based on aggregate information from My MarketBeat watchlists, some other companies that MorphoSys investors own include Novo Nordisk A/S (NVO), Bristol Myers Squibb (BMY), NVIDIA (NVDA), SolarEdge Technologies (SEDG), Gilead Sciences (GILD), AbbVie (ABBV) and Abbott Laboratories (ABT).

Industry, Sector and Symbol

Stock Exchange
ETR
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
ETR:MOR
CIK
N/A
Fax
N/A
Employees
730
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
(€12.24)
Trailing P/E Ratio
N/A
Forward P/E Ratio
322.58
P/E Growth
0.06
Net Income
-€460.81 million
Net Margins
-226.08%
Pretax Margin
N/A
Return on Equity
742.62%
Return on Assets
-13.84%

Debt

Debt-to-Equity Ratio
-96.49
Current Ratio
1.38
Quick Ratio
3.49

Sales & Book Value

Annual Sales
€203.82 million
Price / Sales
12.43
Cash Flow
€129.73 per share
Price / Cash Flow
0.52
Book Value
(€6.96) per share
Price / Book
-9.67

Miscellaneous

Outstanding Shares
37,662,715
Free Float
N/A
Market Cap
€2.53 billion
Optionable
Not Optionable
Beta
0.66
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (ETR:MOR) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners